Covid-19 In Patient With Sarcoidosis Receiving Long-Term Hydroxychloroquine Treatment, France, 2020

François Bénézit,Audrey Le Bot,Stéphane Jouneau,Florian Lemaître,Charlotte Pronier,Pierre-Axel Lentz,Solène Patrat-Delon,Matthieu Revest,Vincent Thibault,Pierre Tattevin

EMERGING INFECTIOUS DISEASES（2020）

引用 12|浏览24

暂无评分

摘要

Because of in vitro studies, hydroxychloroquine has been evaluated as a preexposure or postexposure prophylaxis for coronavirus disease (COVID-19) and as a possible COVID-19 curative treatment. We report a patient with sarcoidosis who was receiving long-term hydroxychloroquine treatment and contracted COVID-19, despite adequate plasma concentrations.

查看译文

关键词

2019 novel coronavirus disease,COVID-19,France,SARS-CoV-2,coronavirus,coronavirus disease,hydroxychloroquine,plasma concentration,respiratory infections,sarcoidosis,severe acute respiratory syndrome coronavirus 2,viruses,zoonoses

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要